皇冠网址（www.hg9988.vip）是一个开放皇冠网址即时比分、皇冠网址代理最新登录线路、皇冠网址会员最新登录线路、皇冠网址代理APP下载、皇冠网址会员APP下载、皇冠网址线路APP下载、皇冠网址电脑版下载、皇冠网址手机版下载的皇冠网址平台。

PETALING JAYA: Malaysian Genomics Resource Centre Bhd (MGRC) has entered into a strategic partnership with Saudi Arabia-based United Doctors Hospital (UDH) for collaboration in genomics and cell therapies.

In a filing with Bursa Malaysia, the genomics and biopharmaceutical specialist said the partnership is valid for three years.

Under the partnership, MGRC and UDH will take the necessary steps to encourage and promote cooperation in the sales and marketing of genetic screening tests and cell therapy products; collaboration in research and development (R&D), and other areas of cooperation in genomics and cell therapies to be mutually decided by both parties.

足球博彩平台（www.hg108.vip）是一个开放皇冠即时比分、代理最新登录线路、会员最新登录线路、皇冠代理APP下载、皇冠会员APP下载、皇冠线路APP下载、皇冠电脑版下载、皇冠手机版下载的皇冠新现金网平台。足球博彩平台上登录线路最新、新2皇冠网址更新最快,足球博彩平台开放皇冠会员注册、皇冠代理开户等业务。

UDH, located in Jeddah, Saudi Arabia, is accredited by the Saudi Central Board for Accreditation of Healthcare Institutions.

“This strategic partnership with UDH enables us to expand the geographical reach of our products and services beyond Malaysia to the Middle East and North Africa region.

“It will also enable us to collaborate on R&D with various domain specialists to enhance our suite of genetic screening tests and cell therapies,” executive director Azri Azerai said in a statement.